2:30-3:10 PM
Infectious Diseases and Antibody Therapy
Keynote Speaker: Davide Corti, Humabs BioMed, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
3:10-3:40 PM
Antibody-mediated immunomodulation: a better understanding for better antiviral immunotherapies
Mireia Pelegrin, Institute for Regenerative Medicine and Biotherapy, INSERM, Montpellier, France
3:40-4:10 PM
Recombinant snakebite antivenoms based on broadly-neutralizing oligoclonal antibodies
Andreas Hougaard Laustsen-Kiel, Technical University of Denmark, Denmark
4:10-4:30 PM
Break - MAGNA HALL, University of Pavia
4:30-5:00 PM
Chicken monoclonal against equine and human rotavirus
Luc Berghman, TAMU, Texas, USA
5:00-5:30 PM
Public-private partnerships for development of mAbs against neglected diseases
James Pettitt, Director, Nonclinical Services, Mapp Biopharmaceutical Inc., San Diego, CA, USA
5:30-6:00 PM
Quality Assessment of Biologics and Biosimilars at Atomic Resolution
Anna Codina, Bruker Biospin